Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ulu, Gizem Tuğçe
66  Ergebnisse:
Personensuche X
?
1

HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Ta..:

Bayram, Nazende Nur ; Ulu, Gizem Tuğçe ; Abdulhadi, Nusaibah Abdulsalam...
Pharmaceutics.  15 (2023)  3 - p. 733 , 2023
Link: https://doi.org/10.3390/..
 
?
2

HER2‐Targeted, Degradable Core Cross‐Linked Micelles for Sp..:

Bayram, Nazende Nur ; Ulu, Gizem Tuğçe ; Topuzoğulları, Murat..
Macromolecular Bioscience.  22 (2021)  1 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
3

List of Contributors:

, In: Biodiversity and Biomedicine,
Abbas, Ghulam ; Ahmed, Nazeer ; Al-Harrasi, Ahmed... - p. xv-xviii , 2020
Link: https://doi.org/10.1016/..
 
?
4

Personalized biomedicine in cancer: from traditional therap..:

, In: Biodiversity and Biomedicine,
Ulu, Gizem Tugce ; Kiraz, Yagmur ; Baran, Yusuf - p. 441-457 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Therapeutic Potentials of İnhibition Jumonji C Domain Conta..:

Koca, Duygu ; Hastar, Nurcan ; Engür, Selin...
Turkish Journal of Hematology.  , 2019
Link: https://doi.org/10.4274/..
 
?
6

HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Ta..:

Bayram, Nazende Nur ; Ulu, Gizem Tuğçe ; Abdulhadi, Nusaibah Abdulsalam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053834/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Peptıde targeted core cross-lınked mıcelles for dox delıver..:

Ulu, Gizem Tuğçe ; Baran, Yusuf ; Bayram, Nazende Nur...
Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı.  , 2022
Link: https://hdl.handle.net/1..
 
?
8

Peptıde targeted core cross-lınked mıcelles for dox delıver..:

Bayram, Nazende Nur ; Ulu, Gizem Tuğçe ; Gürdap, Seda...
Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı.  , 2022
Link: https://hdl.handle.net/1..
 
?
9

PEPTIDE TARGETED CORE CROSS-LINKED MICELLES FOR DOX DELIVER..:

Bayram, Nazende Nur ; Ulu, Gizem Tugce ; Gurdap, Seda...
https://aperta.ulakbim.gov.tr/record/255783.  , 2022
Link: https://aperta.ulakbim.g..
 
?
10

HER2-Targeted, Degradable Core Cross-Linked Micelles for Sp..:

Bayram, Nazende Nur ; Ulu, Gizem Tugce ; Topuzogullari, Murat..
https://aperta.ulakbim.gov.tr/record/237636.  , 2022
Link: https://aperta.ulakbim.g..
 
?
11

Advantage of co-culture strategy for targeted cancer treatm..:

Baran, Yusuf ; Ulu, Gizem Tuğçe ; Bayram, Nazende Nur.
Annals of Oncology.  , 2021
Link: https://hdl.handle.net/1..
 
?
12

Advantage of co-culture strategy for targeted cancer treatm..:

Ulu, Gizem Tuğçe ; Bayram, Nazende Nur ; Dinçer İşoğlu, Sevil.
Annals of Oncology.  , 2021
Link: https://hdl.handle.net/1..
 
?
13

Determination of therapeutic effects of multifunctional mic..:

Baran, Yusuf ; Isoglu, A ; Isoglu, S. D...
Annals Of Oncology.  , 2021
Link: https://hdl.handle.net/1..
 
?
14

Advantage of co-culture strategy for targeted cancer treatm..:

Bayram, Nurun Nisa ; Isoglu, Sevil Dincer ; Baran, Yael.
10.1016/j.annonc.2021.08.309.  , 2021
Link: https://hdl.handle.net/2..
 
?
15

Therapeutic Potentials of Inhibition of Jumonji C Domain - ..:

Koca, Duygu ; Hastar, Nurcan ; Engur, Selin...
https://aperta.ulakbim.gov.tr/record/11181.  , 2020
Link: https://aperta.ulakbim.g..
 
1-15